222
Views
32
CrossRef citations to date
0
Altmetric
Biomarkers

A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients

, , , , , , , & show all
Pages 406-413 | Received 21 Jan 2013, Accepted 01 Apr 2013, Published online: 16 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rafael Franco, Alejandro Lillo, Gemma Navarro & Irene Reyes-Resina. (2022) The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases. Expert Opinion on Therapeutic Targets 26:9, pages 791-800.
Read now

Articles from other publishers (31)

Francesca Provenzano, Carola Torazza, Tiziana Bonifacino, Giambattista Bonanno & Marco Milanese. (2023) The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity. International Journal of Molecular Sciences 24:20, pages 15430.
Crossref
Carlos Sousa-Soares, José Bernardo Noronha-Matos & Paulo Correia-de-Sá. (2023) Purinergic Tuning of the Tripartite Neuromuscular Synapse. Molecular Neurobiology 60:7, pages 4084-4104.
Crossref
Cinzia Volonté, Justin J. Yerbury & Ronald Sluyter. 2023. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration 223 258 .
Nádia Rei, Cláudia A. Valente, Sandra H. Vaz, Miguel Farinha-Ferreira, Joaquim A. Ribeiro & Ana M. Sebastião. (2022) Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine. PLOS ONE 17:12, pages e0272104.
Crossref
Davide Bassani, Matteo Pavan, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese & Stefano Moro. (2022) The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?. International Journal of Molecular Sciences 23:9, pages 4504.
Crossref
Ching-Pang Chang, Kuo-Chen Wu, Chien-Yu Lin & Yijuang Chern. (2021) Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases. Journal of Biomedical Science 28:1.
Crossref
Stefania Gessi, Tino Emanuele Poloni, Giulia Negro, Katia Varani, Silvia Pasquini, Fabrizio Vincenzi, Pier Andrea Borea & Stefania Merighi. (2021) A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease. Cells 10:9, pages 2344.
Crossref
Akihisa Mori, Brittany Cross, Shinichi Uchida, Jill Kerrick Walker & Robert Ristuccia. (2021) How Are Adenosine and Adenosine A2A Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?. Biomedicines 9:8, pages 1027.
Crossref
Ana Moreira-de-Sá, Vanessa S. Lourenço, Paula M. Canas & Rodrigo A. Cunha. (2021) Adenosine A2A Receptors as Biomarkers of Brain Diseases. Frontiers in Neuroscience 15.
Crossref
Mercedes Garcia-Gil, Marcella Camici, Simone Allegrini, Rossana Pesi & Maria Grazia Tozzi. (2021) Metabolic Aspects of Adenosine Functions in the Brain. Frontiers in Pharmacology 12.
Crossref
Muhmmad AtifAbdullah AlsrhaniFarrah NazMuhammad ImranMuhammad ImranMuhammad Ikram UllahAyman A.M. AlameenTanweer Aslam GondalQaisar Raza. (2021) Targeting Adenosine Receptors in Neurological Diseases. Cellular Reprogramming 23:2, pages 57-72.
Crossref
Héctor Godoy-Marín, Romain Duroux, Kenneth A. Jacobson, Concepció Soler, Hildegard Colino-Lage, Veronica Jiménez-Sábado, José Montiel, Leif Hove-Madsen & Francisco Ciruela. (2021) Adenosine A2A Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients. International Journal of Molecular Sciences 22:7, pages 3467.
Crossref
Catarina Miranda-Lourenço, Leonor Ribeiro-Rodrigues, João Fonseca-Gomes, Sara R. Tanqueiro, Rita F. Belo, Catarina B. Ferreira, Nádia Rei, Mafalda Ferreira-Manso, Carolina de Almeida-Borlido, Tiago Costa-Coelho, Céline Felicidade Freitas, Svitlana Zavalko, Francisco M. Mouro, Ana M. Sebastião, Sara Xapelli, Tiago M. Rodrigues & Maria J. Diógenes. (2020) Challenges of BDNF-based therapies: From common to rare diseases. Pharmacological Research 162, pages 105281.
Crossref
Silvia Pasquini, Fabrizio Vincenzi, Ilaria Casetta, Michele Laudisi, Stefania Merighi, Stefania Gessi, Pier Andrea Borea & Katia Varani. (2020) Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes. Cells 9:5, pages 1072.
Crossref
Yijuang ChernNádia ReiJoaquim A. RibeiroAna M. Sebastião. (2019) Adenosine and Its Receptors as Potential Drug Targets in Amyotrophic Lateral Sclerosis. Journal of Caffeine and Adenosine Research 9:4, pages 157-166.
Crossref
Monica Armida, Alessandra Matteucci, Antonella Pèzzola, Younis Baqi, Christa E. Müller, Patrizia Popoli & Rosa Luisa Potenza. (2019) Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice. Neurochemical Research 44:5, pages 1037-1042.
Crossref
M. Cieślak, K. Roszek & M. Wujak. (2018) Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives. Purinergic Signalling 15:1, pages 1-15.
Crossref
Roberta Andrejew, Talita Glaser, Ágatha Oliveira-Giacomelli, Deidiane Ribeiro, Mariana Godoy, Alessandro Granato & Henning Ulrich. 2019. Stem Cells. Stem Cells 275 353 .
Tatiana Al Reef & Esther Ghanem. (2018) Caffeine: Well-known as psychotropic substance, but little as immunomodulator. Immunobiology 223:12, pages 818-825.
Crossref
Dass S Vinay & Byoung S Kwon. (2018) Harnessing immune checkpoints for cancer therapy. Immunotherapy 10:14, pages 1265-1284.
Crossref
Ana M. Sebastião, Nádia Rei & Joaquim A. Ribeiro. (2018) Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors. Frontiers in Pharmacology 9.
Crossref
Ágatha Oliveira-Giacomelli, Yahaira Naaldijk, Laura Sardá-Arroyo, Maria C. B. Gonçalves, Juliana Corrêa-Velloso, Micheli M. Pillat, Héllio D. N. de Souza & Henning Ulrich. (2018) Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy. Frontiers in Pharmacology 9.
Crossref
Sonja Hinz, Gemma Navarro, Dasiel Borroto-Escuela, Benjamin F. Seibt, York-Christoph Ammon, Elisabetta de Filippo, Azeem Danish, Svenja K. Lacher, Barbora Červinková, Muhammad Rafehi, Kjell Fuxe, Anke C. Schiedel, Rafael Franco & Christa E. Müller. (2018) Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors. Oncotarget 9:17, pages 13593-13611.
Crossref
Antonella Ferrante, Roberta De Simone, Maria Antonietta Ajmone-Cat, Luisa Minghetti & Patrizia Popoli. 2018. The Adenosine Receptors. The Adenosine Receptors 217 237 .
Aren van Waarde, Rudi A. J. O. Dierckx, Xiaoyun Zhou, Shivashankar Khanapur, Hideo Tsukada, Kiichi Ishiwata, Gert Luurtsema, Erik F. J. de Vries & Philip H. Elsinga. (2018) Potential Therapeutic Applications of Adenosine A 2A Receptor Ligands and Opportunities for A 2A Receptor Imaging . Medicinal Research Reviews 38:1, pages 5-56.
Crossref
Antonella Ferrante, Maria T. Tebano, Alberto Martire, Maria R. Domenici & Patrizia Popoli. 2017. Adenosine Receptors in Neurodegenerative Diseases. Adenosine Receptors in Neurodegenerative Diseases 131 150 .
Cinzia Volonté, Savina Apolloni, Chiara Parisi & Susanna Amadio. (2016) Purinergic contribution to amyotrophic lateral sclerosis. Neuropharmacology 104, pages 180-193.
Crossref
Filipe Nascimento, Ana M. Sebastião & Joaquim A. Ribeiro. (2015) Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission. Purinergic Signalling 11:4, pages 471-480.
Crossref
A.J. Kwilasz, P.M. Grace, P. Serbedzija, S.F. Maier & L.R. Watkins. (2015) The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology 96, pages 55-69.
Crossref
Seng kah Ng, Haruki Higashimori, Michaela Tolman & Yongjie Yang. (2015) Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology 267, pages 115-122.
Crossref
Filipe Nascimento, Paula A. Pousinha, Alexandra M. Correia, Rui Gomes, Ana M. Sebastião & Joaquim A. Ribeiro. (2014) Adenosine A2A Receptors Activation Facilitates Neuromuscular Transmission in the Pre-Symptomatic Phase of the SOD1(G93A) ALS Mice, but Not in the Symptomatic Phase. PLoS ONE 9:8, pages e104081.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.